Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why training is the key to successful guideline implementation.

A D Paltiel1, P J Neumann

  • 1Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, Connecticut, USA. david.paltiel@yale.edu

Pharmacoeconomics
|August 5, 1997
PubMed
Summary

The growing demand for pharmacoeconomic analysis outstrips training capacity, potentially compromising study integrity. Enhancing investigator skills through targeted education and practice guidelines is crucial for the field’s credibility.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does gabapentin provide benefit for patients with knee OA? A benefit-harm and cost-effectiveness analysis.

Osteoarthritis and cartilage·2022
Same author

Cost-effectiveness of health coaching and financial incentives to promote physical activity after total knee replacement.

Osteoarthritis and cartilage·2018
Same author

Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: a model-based evaluation.

Osteoarthritis and cartilage·2018
Same author

The Value of Risk-Stratified Information in the National Lung Cancer Screening Trial.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Do Specialty Drugs Offer Greater Value for Money Than Traditional Drugs?

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Model-based evaluation of cost-effectiveness of nerve growth factor inhibitors in knee osteoarthritis: impact of drug cost, toxicity, and means of administration.

Osteoarthritis and cartilage·2016

Area of Science:

  • Health Economics
  • Pharmaceutical Policy

Background:

  • The pharmacoeconomic analysis market is expanding rapidly.
  • There is a growing demand for skilled pharmacoeconomic investigators.
  • Current training capacity in academia and industry is insufficient to meet this demand.

Purpose of the Study:

  • To address concerns about the lack of qualified professionals in pharmacoeconomic analysis.
  • To highlight the potential impact on the credibility and integrity of economic evaluation studies.
  • To propose solutions for improving the quality of pharmacoeconomic analysis.

Main Methods:

  • The study is an opinion piece based on the authors' assessment of the field.
  • It reviews the current state of training and professional development in pharmacoeconomics.

Related Experiment Videos

  • It discusses the implications of skill gaps on study quality.

    • Main Results:

    • Many professionals performing cost-effectiveness and economic evaluations may lack essential skills.
    • This skill deficit raises concerns about the reliability of drug-related economic studies.
    • Self-imposed practice guidelines are a necessary but insufficient measure.

    Conclusions:

    • A collaborative effort between academia and industry is needed for long-term solutions.
    • Targeted graduate training in pharmacoeconomic methods is essential.
    • Providing continuing professional education opportunities is critical for maintaining field integrity.